Patents Assigned to CYCLE PHARMACEUTICALS LTD
  • Pharmaceutical composition
    Patent number: 10328029
    Abstract: The present invention relates to oral pharmaceutical compositions comprising nitisinone, or a pharmaceutically acceptable salt thereof, their use in the treatment of tyrosinemia, such as Hereditary Tyrosinemia type-1 (HT-1), or alkaptonuria. The compositions have improved stability characteristics. The invention also relates to processes for producing nitisinone.
    Type: Grant
    Filed: January 5, 2015
    Date of Patent: June 25, 2019
    Assignee: CYCLE PHARMACEUTICALS LTD
    Inventors: James Harrison, Stephen Fuller, Tobias Josef Brown